ArticlePharmaceutical science advances2026

Discovery of novel Kir4.1 inhibitors based on serdemetan with potential therapy for glioblastoma-depression comorbidity.

Hao Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.